Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
J Clin Endocrinol Metab
    May 2023
  1. SU S, Fan J, Yang Y, Yang C, et al
    Birth weight, cardiometabolic factors and coronary heart disease: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2023 May 29:dgad308. doi: 10.1210.
    >> Share

    April 2023
  2. LANG X, Zhao B, Fang S, Li L, et al
    Higher peripheral thyroid sensitivity is linked to a lower risk of heart failure after acute myocardial infarction.
    J Clin Endocrinol Metab. 2023 Apr 27:dgad240. doi: 10.1210.
    >> Share

  3. WANG C, Xin Q, Zheng M, Liu S, et al
    Association of Resting Heart Rate Trajectories with Cardiovascular Disease and Mortality in Diabetes Mellitus Patients.
    J Clin Endocrinol Metab. 2023 Apr 21:dgad228. doi: 10.1210.
    >> Share

  4. MUKAMA T, Srour B, Johnson T, Katzke V, et al
    IGF-1 and risk of morbidity and mortality from cancer, cardiovascular diseases, and all-causes in EPIC - Heidelberg.
    J Clin Endocrinol Metab. 2023 Apr 17:dgad212. doi: 10.1210.
    >> Share

  5. PEI J, Liu C, Yang Z, Lai Y, et al
    Association of KATP Variants With CMD and RAP in CAD Patients With Increased Serum Lipoprotein(a) Levels.
    J Clin Endocrinol Metab. 2023;108:1061-1074.
    >> Share

    March 2023
  6. DEI CAS A, Aldigeri R, Mantovani A, Masulli M, et al
    Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Mar 7:dgad127. doi: 10.1210.
    >> Share

    February 2023
  7. MUKHOPADHYAY P, Sanyal D, Chatterjee P, Pandit K, et al
    SGLT2 inhibitors: Effect on myocardial infarction and stroke in type 2 diabetes.
    J Clin Endocrinol Metab. 2023 Feb 28:dgad113. doi: 10.1210.
    >> Share

  8. HU T, Shen Y, Cao W, Xu Y, et al
    The association and joint effect of adipocyte fatty acid-binding protein and obesity phenotype with cardiovascular events.
    J Clin Endocrinol Metab. 2023 Feb 27:dgad110. doi: 10.1210.
    >> Share

  9. LIN J, Yang L, Huang J, Liu Y, et al
    Insulin-like Growth Factor 1 and Risk of Cardiovascular Disease: Results from the UK Biobank Cohort Study.
    J Clin Endocrinol Metab. 2023 Feb 22:dgad105. doi: 10.1210.
    >> Share

    January 2023
  10. HORTON WB, Snell-Bergeon JK
    HbA1c Variability Metrics Predict Coronary Artery Calcium and Cardiovascular Events in Type 1 Diabetes: the CACTI Study.
    J Clin Endocrinol Metab. 2023 Jan 13:dgad019. doi: 10.1210.
    >> Share

    December 2022
  11. GENG T, Chen JX, Zhou YF, Lu Q, et al
    Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2022 Dec 27:dgac750. doi: 10.1210.
    >> Share

    November 2022
  12. BLIUC D, Tran T, Chen W, Alarkawi D, et al
    Anti-resorptive medication use is not associated with acute cardiovascular risk: An observational study: Anti-resorptive medication and cardiovascular risk.
    J Clin Endocrinol Metab. 2022 Nov 21:dgac669. doi: 10.1210.
    >> Share

  13. YE C, Kong L, Wang Y, Lin H, et al
    Causal associations between age at diagnosis of diabetes and cardiovascular outcomes: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Nov 14. pii: 6825732. doi: 10.1210.
    >> Share

  14. BHADADA SK, Malhotra B, Shetty AJ
    Body weight variability and cardiovascular health in diabetes.
    J Clin Endocrinol Metab. 2022 Nov 1. pii: 6785762. doi: 10.1210.
    >> Share

    October 2022

  15. Correction to "New Horizons: Revival of Lipoprotein (a) as a Risk Factor for Cardiovascular Disease".
    J Clin Endocrinol Metab. 2022 Oct 20. pii: 6764776. doi: 10.1210.
    >> Share

    September 2022
  16. WU VC, Peng KY, Hu YH, Chang CC, et al
    Circulating Plasma Concentrations of ACE2 in Primary Aldosteronism and Cardiovascular Outcomes.
    J Clin Endocrinol Metab. 2022 Sep 19. pii: 6705062. doi: 10.1210.
    >> Share

  17. NESTEL P, Loh WJ, Ward NC, Watts GF, et al
    New Horizons: Revival of Lipoprotein (a) as a risk factor for cardiovascular disease.
    J Clin Endocrinol Metab. 2022 Sep 15. pii: 6701631. doi: 10.1210.
    >> Share


  18. Correction to: "Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes".
    J Clin Endocrinol Metab. 2022 Sep 14. pii: 6698734. doi: 10.1210.
    >> Share

  19. LI Y, Gao R, Zhao B, Zhang Y, et al
    Low serum bicarbonate levels increased the risk of all-cause, cardiovascular and cancer Mortality in type 2 diabetes.
    J Clin Endocrinol Metab. 2022 Sep 6. pii: 6692819. doi: 10.1210.
    >> Share

  20. WEI H, Zhao M, Wu J, Li C, et al
    Association of Systemic Trimethyllysine with Heart Failure with Preserved Ejection Fraction and Cardiovascular Events.
    J Clin Endocrinol Metab. 2022 Sep 5. pii: 6691858. doi: 10.1210.
    >> Share

    August 2022
  21. DONG Y, Chen Z, Gong Y, Han Y, et al
    The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis (jc.2022-01089).
    J Clin Endocrinol Metab. 2022 Aug 16. pii: 6666536. doi: 10.1210.
    >> Share

  22. DONG Y, Chen Z, Gong Y, Han Y, et al
    The Risks of Cardiovascular Disease Following Weight Change in Adults with Diabetes: A Cohort Study and Meta-analysis.
    J Clin Endocrinol Metab. 2022 Aug 15. pii: 6666536. doi: 10.1210.
    >> Share

    June 2022
  23. HOU T, Li M, Lin H, Zhao Z, et al
    The causal effect of systolic blood pressure lowering on vascular outcomes in diabetes: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Jun 15. pii: 6608757. doi: 10.1210.
    >> Share

    May 2022
  24. CHOI HR, Chang Y, Kim Y, Cho Y, et al
    Ideal cardiovascular health metrics and risk of incident early-onset vasomotor symptoms among premenopausal women.
    J Clin Endocrinol Metab. 2022 May 21. pii: 6590294. doi: 10.1210.
    >> Share

  25. LETO G, Tartaglione L, Rotondi S, Pasquali M, et al
    Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease.
    J Clin Endocrinol Metab. 2022 May 20. pii: 6590071. doi: 10.1210.
    >> Share

    April 2022
  26. CUKIERMAN-YAFFE T, Gerstein HC, Basile J, Bethel MA, et al
    Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
    J Clin Endocrinol Metab. 2022 Apr 21. pii: 6569991. doi: 10.1210.
    >> Share

  27. SUZUKI Y, Kaneko H, Okada A, Matsuoka S, et al
    Prediabetes in Young Adults and Its Association with Cardiovascular Health Metrics in the Progression to Diabetes.
    J Clin Endocrinol Metab. 2022 Apr 21. pii: 6572042. doi: 10.1210.
    >> Share

  28. DENG X, Zhang C, Wang P, Wei W, et al
    Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes.
    J Clin Endocrinol Metab. 2022 Apr 9. pii: 6565990. doi: 10.1210.
    >> Share

    March 2022
  29. DAM V, Onland-Moret NC, Burgess S, Chirlaque MD, et al
    Genetically determined reproductive aging and coronary heart disease: a bidirectional two-sample Mendelian Randomization.
    J Clin Endocrinol Metab. 2022 Mar 20. pii: 6550950. doi: 10.1210.
    >> Share

  30. NASR A, Matthews K, Janssen I, Brooks MM, et al
    Associations of abdominal and cardiovascular adipose tissue depots with HDL metrics in midlife women: The SWAN Study.
    J Clin Endocrinol Metab. 2022 Mar 17. pii: 6550277. doi: 10.1210.
    >> Share

  31. JIANG W, Song Q, Zhang J, Chen Y, et al
    The Association of Consumption Time for Food With Cardiovascular Disease and All-Cause Mortality Among Diabetic Patients.
    J Clin Endocrinol Metab. 2022 Mar 15. pii: 6546321. doi: 10.1210.
    >> Share

    February 2022
  32. CHEN D, Zhang Y, Yidilisi A, Xu Y, et al
    Causal associations between circulating adipokines and cardiovascular disease: A Mendelian randomization study.
    J Clin Endocrinol Metab. 2022 Feb 3. pii: 6521299. doi: 10.1210.
    >> Share

    November 2021
  33. YANG J, Zheng Y, Li C, Liu YP, et al
    The impact of subclinical hyperthyroidism on cardiovascular prognosis in patients undergoing PCI.
    J Clin Endocrinol Metab. 2021 Nov 29. pii: 6446179. doi: 10.1210.
    >> Share

  34. SRINIVASA S, Thomas TS, Feldpausch MN, Adler GK, et al
    Coronary Vasculature and Myocardial Structure in HIV: Physiologic Insights From the Renin-Angiotensin-Aldosterone System.
    J Clin Endocrinol Metab. 2021;106:3398-3412.
    >> Share

  35. SAATMANN N, Zaharia OP, Strassburger K, Pesta DH, et al
    Physical fitness and cardiovascular risk factors in the novel diabetes subgroups.
    J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423502. doi: 10.1210.
    >> Share

  36. ZUO Y, Han X, Tian X, Chen S, et al
    Association of Impaired Fasting Glucose with Cardiovascular Disease in the Absence of Risk Factor.
    J Clin Endocrinol Metab. 2021 Nov 8. pii: 6423498. doi: 10.1210.
    >> Share

    October 2021
  37. HONG S, Park JH, Han K, Lee CB, et al
    Association between Obesity and Cardiovascular Disease in Elderly Patients with Diabetes: A Retrospective Cohort Study.
    J Clin Endocrinol Metab. 2021 Oct 1. pii: 6379050. doi: 10.1210.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016